Aspirin Dosing Considerations In Essential Thrombocythemia: The ARES Trial Overview In patients diagnosed with essential thrombocythemia (ET), the standard treatment involves once-daily low-dose aspirin to mitigate the risk of thrombosis. However, due to accelerated platelet turnover in these patients, the antiplatelet effect of aspirin diminishes over time. A study called the Short-term
Tag: antiplatelet therapy
Dual Antiplatelet Therapy To Challenge Tirofiban For Safest Subarachnoid Hemorrhage Therapy
Dual Antiplatelet Therapy To Challenge Tirofiban For Safest Subarachnoid Hemorrhage Therapy Overview In the realm of treating aneurysmal subarachnoid hemorrhage patients with stent-assisted embolization, the management of perioperative complications, particularly thromboembolic events (TEs) and hemorrhagic events (HEs), is crucial, with antiplatelet protocols playing a pivotal role. In this retrospective single-center analysis, a comparison
